Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 328 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Fetal Complications Clear all

Conditions: Chorioamnionitis, Intrapartum Fever, Intra-amniotic Infection
Interventions: Standard Antibiotic Treatment, No Antibiotic Treatment; Drug · Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 50 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Obstetric Labor Complications
Interventions: Ferric derisomaltose; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Fetal Membranes, Premature Rupture
Interventions: non- intervention study; Other
Lead sponsor: Pro-Lab Diagnostics; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 6
States / cities: Birmingham, Alabama • Indianapolis, Indiana • Dallas, Texas + 2 more

Conditions: Fetal Growth Restriction, USCOM
Interventions: USCOM; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Gestational Diabetes Mellitus, Gestational Diabetes Mellitus in Pregnancy, Insulin Resistance
Interventions: Acute exercises sessions with different exercise types and intensities; Behavioral
Lead sponsor: University of Central Arkansas; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Conway, Arkansas

Conditions: Hydrops Fetalis, Fetal Growth Retardation
Interventions: Tandem MS test for inborn errors of metabolism; Procedure
Lead sponsor: Obstetrix Medical Group; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 11
States / cities: Phoenix, Arizona • Laguna Hills, California • Long Beach, California + 6 more

Conditions: Fetal Growth Retardation
Interventions: somatropin (rDNA); Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 8 Years to 12 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Premature Birth, Pregnancy Preterm, Prenatal Stress, Depression, Anxiety, Depression, Postpartum, Satisfaction, Patient, Health Problems in Pregnancy
Interventions: Glow! Group Prenatal Care, Individual Prenatal Care with CPSP; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: Female only
Enrollment: 678 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Fresno, California • San Francisco, California

Conditions: HIV Infections, Pregnancy
Interventions: Nevirapine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 2,009 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2001
U.S. locations: 69
States / cities: Birmingham, Alabama • Mobile, Alabama • La Jolla, California + 40 more

Conditions: Cardiovascular Phenotype, Metabolic Phenotype, Hypertensive Disease, Psychological Phenotype, Audio
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 99 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Fetal Macrosomia, Obesity Complicating Childbirth, Gestational Diabetes
Interventions: Observation; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: Not listed
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Pre-eclampsia, Intrauterine Growth Retardation
Interventions: Modernized prenatal care; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Up to 35 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gestational Diabetes
Interventions: Mellitus GCD59 Test; Diagnostic Test
Lead sponsor: Mellitus, LLC; Industry
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 19
States / cities: Birmingham, Alabama • Orange, California • Aurora, Colorado + 16 more

Conditions: Obesity, Lifestyle-related Condition, Macrosomia, Fetal
Interventions: Lifestyle Intervention; Behavioral
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 143 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2025
U.S. locations: 4
States / cities: Baton Rouge, Louisiana • Boston, Massachusetts • Cleveland, Ohio

Conditions: Congenital Adrenal Hyperplasia
Interventions: Questionnaires/Interviews; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 10 Years to 13 Years · Female only
Enrollment: 188 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Intrauterine Growth Restriction
Interventions: Pomegranate Juice, Placebo; Dietary Supplement
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Circulating Cell Free Fetal DNA, Intrauterine Fetal Demise, Miscarriage
Interventions: Not listed
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Lactation Disorder - Postpartum Condition or Complication, Nutrition, Healthy
Interventions: Ritual Epre Multimineral-Vitamin Supplement, Placebo Control; Dietary Supplement
Lead sponsor: City University of New York; Other
Eligibility: 18 Years and older · Female only
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Brooklyn, New York

Conditions: Prenatal Exposure Delayed Effects, Multiple Sclerosis, Pregnancy
Interventions: BG9418 (interferon beta-1a); Drug
Lead sponsor: Biogen; Industry
Eligibility: Female only
Enrollment: 329 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Premature Labor
Interventions: Abdominal fetal/maternal monitoring; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Pregnant Women, Gestational Diabetes, Obese But Otherwise Healthy Participants, Overweight (BMI > 25), Gestational Diabetes Mellitus in Pregnancy
Interventions: Pregnancy Physical Activity Questionnaire (PPAQ); Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Electronic Fetal Monitoring, Fetal Hypoxia, Fetal-Placental Circulation
Interventions: Room air, 10L Oxygen by nonrebreather mask; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Postpartum Depression, Child Development, Parenting, Child Self-Regulation
Interventions: Mothers and Babies; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Months and older
Enrollment: 960 participants
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Down Syndrome (Trisomy 21), Edward's Syndrome (Trisomy 18), Patau Syndrome (Trisomy 13), Klinefelter Syndrome (47, XXY), and Other Chromosome, Abnormalities.
Interventions: Not listed
Lead sponsor: Lenetix Medical Screening Laboratory; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 7
States / cities: Rockville, Maryland • Moristown, New Jersey • Mineola, New York + 3 more

Search by objective public record fields.

Intrapartum Fever: Antibiotics Versus no Treatment

Monoferric for Prenatal Iron Deficiency

PROMComplete for Determination of Rupture of Fetal Membranes

USCOM in Newly Diagnosed FGR Cases

Prenatal Exercise and Glucose Regulation

Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR

Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

Engaging Mothers & Babies; Reimagining Antenatal Care for Everyone (EMBRACE) Study

A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies

Implications of Maternal 45,X Mosaicism as a Secondary Genomic Finding Following Cell-Free DNA Sequencing During Pregnancy: A Deep Phenotype Study

Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes

A Modernized Approach to Prenatal Care in Low Risk Women

Protocol to Validate the Performance of the Mellitus Glycated CD59 ELISA for Gestational Diabetes Screening

Lifestyle Intervention in Preparation for Pregnancy (LIPP)

Tweens to Teens Project at Penn State

Impact of Maternal Pomegranate Juice on Brain Injury in Infants With Intrauterine Growth Restriction (IUGR)

The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage

Use of Ritual Epost Postnatal Multivitamins During the Postpartum Period

Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)

Performance of the Monica Novii Wireless Patch System in Pre-term Labor

Physical Acvitiy in Pregnancy

Oxygen for Intrauterine Resuscitation of Category II Fetal Heart Tracings

Prenatal Depression Prevention Effects on Parenting and Young Child Self-Regulation and Functioning

Non-Invasive Determination of Fetal Chromosome Abnormalities